Testing Firsekibart to Prevent Gout Attacks
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study tests whether a new drug called firsekibart can help prevent gout from coming back. If you've had multiple gout attacks in the past year and are currently having one, this trial may help you and advance gout treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with gout using standard medical criteria
- You have had at least 2 gout attacks in the past 12 months
- You are currently experiencing an acute gout attack (flare)
- You have no serious heart, lung, or immune system conditions
- You are not pregnant, breastfeeding, or allergic to the study drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This trial tests whether a tart cherry effervescent tablet can help lower uric acid levels in people who have high uric acid but have never had a gout attack. High uric acid can lead to gout and other health problems, so finding a safe way to lower it might help prevent these complications.
This trial tests whether taking firsekibart (a gout prevention injection) on a regular schedule works better than taking it only when needed. You would be eligible if you've already completed 24 weeks of firsekibart without gout flares and are willing to continue gout-lowering medications.
This trial tests a new tablet called BR2251 for people with gout and high uric acid. It aims to lower uric acid levels and manage gout symptoms.
This study tests if a type 2 diabetes medication (SGLT2 inhibitor) can help people with frequent gout flares. It aims to lower uric acid levels and reduce flare-ups.
This trial tests a new tablet (HR091506) for adults with gout and high uric acid. It aims to lower uric acid levels and reduce gout attacks, especially for people with more severe gout (like tophi or frequent attacks).
Hear when a new Gout Flare trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.